Bayer investor sues top executives for 'disastrous' Monsanto deal

Bayer shares are down 31% since the company completed the $63 billion takeover of Monsanto, prompting some investors to demand the resignation of Chief Executive Officer Werner Baumann.

A Bayer AG investor sued the board and other top company officials, claiming the “disastrous” 2018 acquisition of Monsanto Co. eroded the company’s share value by saddling it with potentially billions of dollars in liability from Roundup lawsuits.
 

Bayer AG’s board and other top officials were sued by an investor who claims the “disastrous” 2018 acquisition of Monsanto Co. saddled the company with potentially billions of dollars in costly lawsuits over Roundup herbicide.

The German chemical giant “has been engulfed by a tsunami” of litigation alleging Monsanto’s Roundup causes cancer, eroding Bayer’s share value, Rebecca Haussmann said in a suit